X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (10) 10
humans (9) 9
male (9) 9
abridged index medicus (7) 7
risk factors (7) 7
adult (6) 6
aged (5) 5
cardiovascular disease (5) 5
diabetes (5) 5
diabetes mellitus (5) 5
female (5) 5
medicine, general & internal (5) 5
middle aged (5) 5
cardiovascular diseases (4) 4
cerebral infarction (4) 4
health risk assessment (4) 4
incidence (4) 4
myocardial infarction (4) 4
risk analysis (4) 4
type 2 diabetes (4) 4
clinical trials (3) 3
complications (3) 3
disease control (3) 3
endocrinology & metabolism (3) 3
health risks (3) 3
heart attacks (3) 3
hemoglobin (3) 3
hypoglycemia (3) 3
liraglutide (3) 3
motivation (3) 3
patients (3) 3
peptides (3) 3
randomization (3) 3
stroke (3) 3
aged, 80 and over (2) 2
agonists (2) 2
antipyrine - metabolism (2) 2
arteriosclerosis (2) 2
base-line (2) 2
blood pressure (2) 2
body mass index (2) 2
cardiovascular diseases - prevention & control (2) 2
cardiovascular outcomes (2) 2
care and treatment (2) 2
case-control studies (2) 2
cholesterol (2) 2
control methods (2) 2
diabetes mellitus, type 2 - complications (2) 2
diabetes mellitus, type 2 - drug therapy (2) 2
diabetic retinopathy (2) 2
disease (2) 2
disease prevention (2) 2
double-blind method (2) 2
drug dosages (2) 2
enzymes (2) 2
events (2) 2
fda approval (2) 2
gastrointestinal surgery (2) 2
glucagon (2) 2
glucagon-like peptide 1 (2) 2
half-life (2) 2
heart rate - drug effects (2) 2
hyperglycemia (2) 2
kidney (2) 2
kidney diseases (2) 2
kinetics (2) 2
lipids (2) 2
metabolism (2) 2
metoprolol - pharmacology (2) 2
microvasculature (2) 2
obesity (2) 2
pindolol - pharmacology (2) 2
reduction (2) 2
rifampin - pharmacology (2) 2
risk groups (2) 2
safety (2) 2
therapy (2) 2
2013 accf/aha guideline (1) 1
administration, oral (1) 1
adolescent (1) 1
adrenergic beta-antagonists - pharmacology (1) 1
albuminuria (1) 1
alcohol (1) 1
american-college (1) 1
analysis (1) 1
angina (1) 1
angina pectoris (1) 1
antibodies - blood (1) 1
antibodies, monoclonal, humanized - adverse effects (1) 1
antibodies, monoclonal, humanized - immunology (1) 1
antibodies, monoclonal, humanized - therapeutic use (1) 1
antibodies; antibodies, monoclonal, humanized; anticholesteremic agents; cardiovascular diseases; cholesterol, ldl; double-blind method; female; follow-up studies; humans; hypercholesterolemia; injections, subcutaneous; lipids; male; middle aged; proprotein convertase 9; risk factors; treatment failure; medicine (1) 1
anticholesteremic agents - adverse effects (1) 1
anticholesteremic agents - immunology (1) 1
anticholesteremic agents - therapeutic use (1) 1
apolipoprotein-ciii (1) 1
appetite (1) 1
association (1) 1
association task-force (1) 1
atenolol - pharmacology (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 01/2019, Volume 380, Issue 4, pp. 347 - 357
In a randomized trial of patients with type 2 diabetes, treatment with dapagliflozin, an SGLT2 inhibitor that promotes glucosuria, did not result in a higher... 
2013 ACCF/AHA GUIDELINE | MEDICINE, GENERAL & INTERNAL | SELECTIVE SGLT2 INHIBITOR | MANAGEMENT | HEART-FAILURE OUTCOMES | DISEASE | AMERICAN-COLLEGE | ASSOCIATION TASK-FORCE | KIDNEY | EMPAGLIFLOZIN | SOCIETY | Cardiovascular Diseases - etiology | Sodium-Glucose Transporter 2 Inhibitors - therapeutic use | Sodium-Glucose Transporter 2 Inhibitors - adverse effects | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Hospitalization - statistics & numerical data | Male | Benzhydryl Compounds - adverse effects | Cardiovascular Diseases - mortality | Female | Glucosides - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Benzhydryl Compounds - therapeutic use | Heart Failure - epidemiology | Diabetes Mellitus, Type 2 - complications | Glucosides - adverse effects | Type 2 diabetes | Safety and security measures | Dapagliflozin | Dosage and administration | Drug therapy | Cardiovascular diseases | Risk factors | Heart failure | Myocardial infarction | Cerebral infarction | End-stage renal disease | Heart attacks | Mortality | Diabetes mellitus | Cardiovascular disease | FDA approval | Patients | Glomerular filtration rate | Heart rate | Ischemia | Sodium | Arteriosclerosis | Ketoacidosis | Death | Diabetes | Kidney diseases | Safety | Diabetes mellitus (non-insulin dependent) | Heart diseases | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2017, Volume 376, Issue 16, pp. 1527 - 1539
Journal Article
by Bohula, Erin A and Scirica, Benjamin M and Inzucchi, Silvio E and Inzucchi, Silvio and McGuire, Darren K and Keech, Anthony C and Keech, Anthony and Smith, Steven R and Smith, S and Kanevsky, Estella and Murphy, Sabina A and Leiter, Lawrence A and Dwyer, Jamie P and Dwyer, Jamie and Corbalan, Ramon and Hamm, Christian and Kaplan, Lee and Nicolau, Jose Carlos and Ophuis, Ton Oude and Ray, Kauski and Ray, Kausik K and Ruda, Mikhail and Spinar, Jindrich and Patel, S and Patel, R and Patel, Tushar and Miao, Wenfeng and Perdomo, Carlos and Francis, Bruce and Dhadda, Shobha and Bonaca, Marc P and Ruff, Christian T and Sabatine, Marc S and Wiviott, Stephen D and Satlin, Andrew and Brown, Conville and Brown, J and Budaj, Andrzej and Garcia-Castillo, Armando and Gupta, N and Gupta, Milan and Oude Ophuis, Ton and Weissman, Neil and White, Harvey D and White, A and White, J and Amerena, J and Arstall, M and Colquhoun, D and Jayasinghe, R and Lee, A and Lee, J and Lehman, R and Moses, R and Proietto, J and Purnell, P and Waites, J and Blombery, P and Cross, D and Worthley, M and d'Emden, M and Selvanayagam, J and Oqueli, RE and Whelan, A and Garrahy, P and de Looze, F and Ninio, D and Horowitz, J and William, M and Suranyi, M and Wittert, G and Le May, M and Pandey, AS and Vizel, S and Labonte, R and Beaudry, Y and Fortin, C and Bell, A and Kouz, S and St-Amour, É and Bata, I and St Maurice, F and Chehayeb, R and Constance, C and Wong, G and Hess, A and Liutkus, J and Poirier, P and Teitelbaum, I and Berlingieri, J and Cha, J and Hartleib, M and Heffernan, M and Twum-Barima, D and Pandith, V and Aronson, R and Goldenberg, R and Ajala, B and Jain, A and Ross, S and ... and CAMELLIA-TIMI61 Steering Comm and CAMELLIA-TIMI 61 Steering Committee Investigators
The Lancet, ISSN 0140-6736, 11/2018, Volume 392, Issue 10161, pp. 2269 - 2279
Journal Article
4.